Skip to main content
Erschienen in: Pediatric Nephrology 9/2014

01.09.2014 | Original Article

Toll-like receptors, immunoproteasome and regulatory T cells in children with Henoch–Schönlein purpura and primary IgA nephropathy

verfasst von: Maria Elena Donadio, Elisa Loiacono, Licia Peruzzi, Alessandro Amore, Roberta Camilla, Federica Chiale, Luca Vergano, Alberto Boido, Margherita Conrieri, Manuela Bianciotto, Francesca Maria Bosetti, Rosanna Coppo

Erschienen in: Pediatric Nephrology | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Henoch–Schönlein purpura (HSP) nephritis and primary IgA nephropathy (pIgAN) present with glomerular IgA deposits, but differ with regard to clinical features. The suspected involvement of different immune system pathways is largely unknown.

Methods

This study was aimed at investigating some of the immunological features including Toll-like receptors (TLR), proteasome (PS)/immunoproteasome (iPS) switch, and the regulatory T cell system (Treg/Th17 cells) in 63 children with HSP with/without renal involvement and in 25 with pIgAN. Real-time PRC (Taqman) was used to quantify mRNA levels in peripheral blood mononuclear cells (PBMC).

Results

The expression of mRNAs encoding for TLR4 in both HSP and pIgAN was higher than in controls (HC) and in both diseases FoxP3mRNA and TGF-β1mRNA expression was significantly lower than in HC. A switch from PS to iPS (LMP2/β1) was detected only in PBMC of HSP and it correlated with the level of TLR2mRNA, which was selectively increased only in children with HSP.

Conclusion

Children with HSP and pIgAN present with similar signs of engagement of the innate immunity and regulatory T cell depression. The increased immunoproteasome switch, which correlated with TLR2 activation, may suggest an innate immunity pathway peculiar to HSP vasculitic presentation. This research area also deserves further investigation for possible therapeutic applications.
Literatur
1.
Zurück zum Zitat Davin JC (2011) Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy. Clin J Am Soc Nephrol 6:679–689PubMedCrossRef Davin JC (2011) Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy. Clin J Am Soc Nephrol 6:679–689PubMedCrossRef
2.
Zurück zum Zitat Coppo R (2008) Pediatric IgA nephropathy: clinical and therapeutic perspectives. Semin Nephrol 28:18–26PubMedCrossRef Coppo R (2008) Pediatric IgA nephropathy: clinical and therapeutic perspectives. Semin Nephrol 28:18–26PubMedCrossRef
3.
Zurück zum Zitat Davin JC, Ten Berge IJ, Weening JJ (2001) What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int 59:823–834PubMedCrossRef Davin JC, Ten Berge IJ, Weening JJ (2001) What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int 59:823–834PubMedCrossRef
4.
Zurück zum Zitat Calvo-Río V, Loricera J, Martín L, Ortiz-Sanjuán F, Alvarez L, González-Vela MC, González-Lamuño D, Mata C, Gortázar P, Rueda-Gotor J, Arias M, Peiró E, Martínez-Taboada VM, González-Gay MA, Blanco R (2013) Henoch-Schönlein purpura nephritis and IgA nephropathy: a comparative clinical study. Clin Exp Rheumatol 31:S45–S51PubMed Calvo-Río V, Loricera J, Martín L, Ortiz-Sanjuán F, Alvarez L, González-Vela MC, González-Lamuño D, Mata C, Gortázar P, Rueda-Gotor J, Arias M, Peiró E, Martínez-Taboada VM, González-Gay MA, Blanco R (2013) Henoch-Schönlein purpura nephritis and IgA nephropathy: a comparative clinical study. Clin Exp Rheumatol 31:S45–S51PubMed
5.
Zurück zum Zitat Bogdanovic R (2009) Henoch-Schönlein purpura nephritis in children: Risk factors, prevention and treatment. Acta Paediatr 98:1882–1889PubMedCrossRef Bogdanovic R (2009) Henoch-Schönlein purpura nephritis in children: Risk factors, prevention and treatment. Acta Paediatr 98:1882–1889PubMedCrossRef
6.
Zurück zum Zitat Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP (1997) Longterm prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura. Nephrol Dial Transplant 12:2277–2283PubMedCrossRef Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP (1997) Longterm prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura. Nephrol Dial Transplant 12:2277–2283PubMedCrossRef
7.
Zurück zum Zitat Edström Halling S, Söderberg MP, Berg UB (2012) Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification). Nephrol Dial Transplant 27:715–722PubMedCrossRef Edström Halling S, Söderberg MP, Berg UB (2012) Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification). Nephrol Dial Transplant 27:715–722PubMedCrossRef
8.
Zurück zum Zitat Shima Y, Nakanishi K, Hama T, Mukaiyama H, Togawa H, Sako M, Kaito H, Nozu K, Tanaka R, Iijima K, Yoshikawa N (2013) Spontaneous remission in children with IgA nephropathy. Pediatr Nephrol 28:71–76PubMedCrossRef Shima Y, Nakanishi K, Hama T, Mukaiyama H, Togawa H, Sako M, Kaito H, Nozu K, Tanaka R, Iijima K, Yoshikawa N (2013) Spontaneous remission in children with IgA nephropathy. Pediatr Nephrol 28:71–76PubMedCrossRef
9.
Zurück zum Zitat Novak J, Julian BA, Mestecky J, Renfrow MB (2012) Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol 34:365–382PubMedCrossRef Novak J, Julian BA, Mestecky J, Renfrow MB (2012) Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol 34:365–382PubMedCrossRef
10.
Zurück zum Zitat Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J (2007) Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol 22:2067–2072PubMedCrossRef Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J (2007) Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol 22:2067–2072PubMedCrossRef
11.
Zurück zum Zitat Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chathan WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J (2009) Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 119:1668–1677PubMedCentralPubMed Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chathan WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J (2009) Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 119:1668–1677PubMedCentralPubMed
13.
Zurück zum Zitat Coppo R, Amore A, Peruzzi L, Vergano L, Camilla R (2010) Innate immunity and IgA nephropathy. J Nephrol 23:626–632PubMed Coppo R, Amore A, Peruzzi L, Vergano L, Camilla R (2010) Innate immunity and IgA nephropathy. J Nephrol 23:626–632PubMed
14.
Zurück zum Zitat Rigante D, Castellazzi L, Bosco A, Esposito S (2013) Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura? Autoimmun Rev 12:1016–1021PubMedCrossRef Rigante D, Castellazzi L, Bosco A, Esposito S (2013) Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura? Autoimmun Rev 12:1016–1021PubMedCrossRef
15.
Zurück zum Zitat Medzhitov R (2007) Recognition of microorganisms and activation of the immune response. Nature 449:819–826PubMedCrossRef Medzhitov R (2007) Recognition of microorganisms and activation of the immune response. Nature 449:819–826PubMedCrossRef
16.
17.
Zurück zum Zitat Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801PubMedCrossRef Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801PubMedCrossRef
19.
Zurück zum Zitat Rock KL, York IA, Saric T (2002) Protein degradation and generation of MHC class I-presented peptides. Adv Immunol 80:1–70PubMedCrossRef Rock KL, York IA, Saric T (2002) Protein degradation and generation of MHC class I-presented peptides. Adv Immunol 80:1–70PubMedCrossRef
20.
Zurück zum Zitat Macagno A, Kuehn L, de Giuli R, Groettrup M (2001) Pronounced up-regulation of the PA28alpha/β proteasome regulator but little increase in the steady state. Content of immunoproteasome during dendritic cell maturation. Eur J Immunol 31:3271–3280PubMedCrossRef Macagno A, Kuehn L, de Giuli R, Groettrup M (2001) Pronounced up-regulation of the PA28alpha/β proteasome regulator but little increase in the steady state. Content of immunoproteasome during dendritic cell maturation. Eur J Immunol 31:3271–3280PubMedCrossRef
21.
Zurück zum Zitat Pedruzzi LM, Stockler-Pinto MB, Leite M Jr, Mafra D (2012) Nrf2-keap1 system versus NF-κB: the good and the evil in chronic kidney disease? Biochimie 94:2461–2466PubMedCrossRef Pedruzzi LM, Stockler-Pinto MB, Leite M Jr, Mafra D (2012) Nrf2-keap1 system versus NF-κB: the good and the evil in chronic kidney disease? Biochimie 94:2461–2466PubMedCrossRef
22.
Zurück zum Zitat Sakaguchi S, Wing K, Miyara M (2007) Regulatory T cells—a brief history and perspective. Eur J Immunol 37 [Suppl 1]:S116–S123PubMedCrossRef Sakaguchi S, Wing K, Miyara M (2007) Regulatory T cells—a brief history and perspective. Eur J Immunol 37 [Suppl 1]:S116–S123PubMedCrossRef
23.
Zurück zum Zitat Beyer M, Schultze JL (2011) Plasticity of Treg cells: is reprogramming of Treg cells possible in the presence of FOXP3? Int Immunopharmacol 11:555–560PubMedCrossRef Beyer M, Schultze JL (2011) Plasticity of Treg cells: is reprogramming of Treg cells possible in the presence of FOXP3? Int Immunopharmacol 11:555–560PubMedCrossRef
24.
Zurück zum Zitat Turner JE, Paust HJ, Steinmetz OM, Panzer U (2010) The Th17 immune response in renal inflammation. Kidney Int 77:1070–1075PubMedCrossRef Turner JE, Paust HJ, Steinmetz OM, Panzer U (2010) The Th17 immune response in renal inflammation. Kidney Int 77:1070–1075PubMedCrossRef
25.
Zurück zum Zitat Coarthay A (2009) How do regulatory T cells work? Scand J Immunol 70:326–366CrossRef Coarthay A (2009) How do regulatory T cells work? Scand J Immunol 70:326–366CrossRef
26.
Zurück zum Zitat Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chsnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Ruperto N (2010) EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara, 2008. II. Final classification criteria. Ann Rheum Dis 69:798–806PubMedCrossRef Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chsnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Ruperto N (2010) EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara, 2008. II. Final classification criteria. Ann Rheum Dis 69:798–806PubMedCrossRef
27.
Zurück zum Zitat Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832–1843PubMedCrossRef Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832–1843PubMedCrossRef
28.
Zurück zum Zitat Coppo R, Camilla R, Amore A, Peruzzi L, Daprà V, Loiacono E, Vatrano S, Rollino C, Sepe V, Rampino T, Dal Canton A (2010) Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy. Clin Exp Immunol 159:73–81PubMedCentralPubMedCrossRef Coppo R, Camilla R, Amore A, Peruzzi L, Daprà V, Loiacono E, Vatrano S, Rollino C, Sepe V, Rampino T, Dal Canton A (2010) Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy. Clin Exp Immunol 159:73–81PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Coppo R, Camilla R, Alfarano A, Balegno S, Mancuso D, Peruzzi L, Amore A, Dal Canton A, Sepe V, Tovo P (2009) Upregulation of the immunoproteasome in peripheral blood mononuclear cells of patients with IgA nephropathy. Kidney Int 75:536–541PubMedCrossRef Coppo R, Camilla R, Alfarano A, Balegno S, Mancuso D, Peruzzi L, Amore A, Dal Canton A, Sepe V, Tovo P (2009) Upregulation of the immunoproteasome in peripheral blood mononuclear cells of patients with IgA nephropathy. Kidney Int 75:536–541PubMedCrossRef
30.
Zurück zum Zitat Lin FJ, Jiang GR, Shan JP, Zhu C, Zou J, Wu XR (2012) Imbalance of regulatory T cells to Th17 cells in IgA nephropathy. Scand J Clin Lab Invest 72:221–229PubMedCrossRef Lin FJ, Jiang GR, Shan JP, Zhu C, Zou J, Wu XR (2012) Imbalance of regulatory T cells to Th17 cells in IgA nephropathy. Scand J Clin Lab Invest 72:221–229PubMedCrossRef
31.
Zurück zum Zitat Jung YO, Cho ML, Lee SY, Oh HJ, Park JS, Park MK, Park MJ, Ju JH, Kim SI, Kim HY, Park SH, Min JK (2009) Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice. Immunol Lett 123:138–143PubMedCrossRef Jung YO, Cho ML, Lee SY, Oh HJ, Park JS, Park MK, Park MJ, Ju JH, Kim SI, Kim HY, Park SH, Min JK (2009) Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice. Immunol Lett 123:138–143PubMedCrossRef
32.
Zurück zum Zitat Shirey KA, Lai W, Scott AJ, Lipsky M, Mistry P, Pletneva LM, Karp CL, McAlees J, Gioannini TL, Weiss J, Chen WH, Ernst RK, Rossignol DP, Gusovsky F, Blanco JC, Vogel SN (2013) The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 497:498–502PubMedCentralPubMedCrossRef Shirey KA, Lai W, Scott AJ, Lipsky M, Mistry P, Pletneva LM, Karp CL, McAlees J, Gioannini TL, Weiss J, Chen WH, Ernst RK, Rossignol DP, Gusovsky F, Blanco JC, Vogel SN (2013) The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 497:498–502PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Mersmann J, Iskandar F, Latsch K, Habeck K, Sprunck V, Zimmermann R, Schumann RR, Zacharowski K, Koch A (2013) Attenuation of myocardial injury by HMGB1 blockade during ischemia/reperfusion is toll-like receptor 2-dependent. Mediators Inflamm 2013:174168PubMedCentralPubMedCrossRef Mersmann J, Iskandar F, Latsch K, Habeck K, Sprunck V, Zimmermann R, Schumann RR, Zacharowski K, Koch A (2013) Attenuation of myocardial injury by HMGB1 blockade during ischemia/reperfusion is toll-like receptor 2-dependent. Mediators Inflamm 2013:174168PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Savva A, Roger T (2013) Targeting Toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases. Front Immunol 18:4–387 Savva A, Roger T (2013) Targeting Toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases. Front Immunol 18:4–387
35.
Zurück zum Zitat Niewerth D, Franke NE, Jansen G, Assaraf YG, van Meerloo J, Kirk CJ, Degenhardt J, Anderl J, Schimmer AD, Zweegman S, de Haas V, Horton TM, Kaspers GJ, Cloos J (2013) Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors. Haematologica 98:1896–1904PubMedCentralPubMedCrossRef Niewerth D, Franke NE, Jansen G, Assaraf YG, van Meerloo J, Kirk CJ, Degenhardt J, Anderl J, Schimmer AD, Zweegman S, de Haas V, Horton TM, Kaspers GJ, Cloos J (2013) Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors. Haematologica 98:1896–1904PubMedCentralPubMedCrossRef
Metadaten
Titel
Toll-like receptors, immunoproteasome and regulatory T cells in children with Henoch–Schönlein purpura and primary IgA nephropathy
verfasst von
Maria Elena Donadio
Elisa Loiacono
Licia Peruzzi
Alessandro Amore
Roberta Camilla
Federica Chiale
Luca Vergano
Alberto Boido
Margherita Conrieri
Manuela Bianciotto
Francesca Maria Bosetti
Rosanna Coppo
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 9/2014
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-014-2807-6

Weitere Artikel der Ausgabe 9/2014

Pediatric Nephrology 9/2014 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.